Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination
Tóm tắt
Trials of coronavirus disease 2019 (COVID-19) vaccination included limited numbers of children, so they may not have detected rare but important adverse events in this population. We report 7 cases of acute myocarditis or myopericarditis in healthy male adolescents who presented with chest pain all within 4 days after the second dose of Pfizer-BioNTech COVID-19 vaccination. Five patients had fever around the time of presentation. Acute COVID-19 was ruled out in all 7 cases on the basis of negative severe acute respiratory syndrome coronavirus 2 real-time reverse transcription polymerase chain reaction test results of specimens obtained by using nasopharyngeal swabs. None of the patients met criteria for multisystem inflammatory syndrome in children. Six of the 7 patients had negative severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody assay results, suggesting no previous infection. All patients had an elevated troponin. Cardiac MRI revealed late gadolinium enhancement characteristic of myocarditis. All 7 patients resolved their symptoms rapidly. Three patients were treated with nonsteroidal antiinflammatory drugs only, and 4 received intravenous immunoglobulin and corticosteroids. In this report, we provide a summary of each adolescent’s clinical course and evaluation. No causal relationship between vaccine administration and myocarditis has been established. Continued monitoring and reporting to the US Food and Drug Administration Vaccine Adverse Event Reporting System is strongly recommended.
Từ khóa
Tài liệu tham khảo
Pfizer-BioNTech . Full emergency use authorization (EUA) prescribing information. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=14471&format=pdf&#page=13. Accessed May 15, 2021
Polack, 2020, Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577
Halsell, 2003, Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel, JAMA, 289, 3283, 10.1001/jama.289.24.3283
Kime P . Pentagon tracking 14 cases of heart inflammation in troops after COVID-19 shots. 2021. Available at: https://www.military.com/daily-news/2021/04/26/pentagon-tracking-14-cases-of-heart-inflammation-troops-after-covid-19-shots.html. Accessed May 16, 2021
Reuters . Israel examining heart inflammation cases in people who received Pfizer COVID shot. Reuters. April 25, 2021. Available at: https://www.reuters.com/world/middle-east/israel-examining-heart-inflammation-cases-people-who-received-pfizer-covid-shot-2021-04-25/. 2021. Accessed May 16, 2021
Ammirati, 2021, Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection, Int J Cardiol Heart Vasc, 34, 100774
Bautista García, 2021, Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19, Rev Esp Cardiol (Engl Ed), 27
Blondiaux, 2020, Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19, Radiology, 297, E283, 10.1148/radiol.2020202288
Ferreira, 2018, Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations, J Am Coll Cardiol, 72, 3158, 10.1016/j.jacc.2018.09.072
Arola, 2017, Occurrence and features of childhood myocarditis: a nationwide study in Finland, J Am Heart Assoc, 6, e005306, 10.1161/JAHA.116.005306
Ghelani, 2012, Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011, Circ Cardiovasc Qual Outcomes, 5, 622, 10.1161/CIRCOUTCOMES.112.965749
Dasgupta, 2019, Myocarditis in the pediatric population: a review, Congenit Heart Dis, 14, 868, 10.1111/chd.12835
Maron, 2015, Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology, J Am Coll Cardiol, 66, 2362, 10.1016/j.jacc.2015.09.035
Adler, 2015, 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 36, 2921, 10.1093/eurheartj/ehv318
Kytö, 2014, Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis, Circulation, 130, 1601, 10.1161/CIRCULATIONAHA.114.010376
Imazio, 2008, Myopericarditis versus viral or idiopathic acute pericarditis, Heart, 94, 498, 10.1136/hrt.2006.104067
Centers for Disease Control and Prevention . Demographic characteristics of people receiving COVID-19 vaccinations in the United States. 2021. Available at: https://covid.cdc.gov/covid-data-tracker/#vaccination-demographic. Accessed May 23, 2021
Arness, 2004, Myopericarditis following smallpox vaccination, Am J Epidemiol, 160, 642, 10.1093/aje/kwh269
Kawakami, 2021, Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week, J Am Coll Cardiol, 77, 314, 10.1016/j.jacc.2020.11.031
Vukomanovic, 2021, Differences between pediatric acute myocarditis related and unrelated to SARS-CoV-2, Pediatr Infect Dis J, 40, e173, 10.1097/INF.0000000000003094
Centers for Disease Control and Prevention . Vaccine recommendations and guidelines of the ACIP. 2021. Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19. Accessed May 23, 2021